OncoCyte Historical Financial Ratios
| OCX Stock | USD 2.44 0.09 3.56% |
OncoCyte Corp is promptly reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 203 will help investors to properly organize and evaluate OncoCyte Corp financial condition quickly.
OncoCyte |
About OncoCyte Financial Ratios Analysis
OncoCyte CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate OncoCyte Corp investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on OncoCyte financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across OncoCyte Corp history.
OncoCyte Corp Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing OncoCyte Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on OncoCyte Corp sales, a figure that is much harder to manipulate than other OncoCyte Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is OncoCyte Corp dividend as a percentage of OncoCyte Corp stock price. OncoCyte Corp dividend yield is a measure of OncoCyte Corp stock productivity, which can be interpreted as interest rate earned on an OncoCyte Corp investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Most ratios from OncoCyte Corp's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into OncoCyte Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OncoCyte Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy OncoCyte Stock please use our How to Invest in OncoCyte Corp guide.At this time, OncoCyte Corp's Days Sales Outstanding is fairly stable compared to the past year. Book Value Per Share is likely to rise to 5.55 in 2024, whereas Price To Sales Ratio is likely to drop 12.09 in 2024.
| 2023 | 2024 (projected) | Dividend Yield | 0.001654 | 0.00147 | Price To Sales Ratio | 12.73 | 12.09 |
OncoCyte Corp fundamentals Correlations
Click cells to compare fundamentals
OncoCyte Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for OncoCyte Stock Analysis
When running OncoCyte Corp's price analysis, check to measure OncoCyte Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoCyte Corp is operating at the current time. Most of OncoCyte Corp's value examination focuses on studying past and present price action to predict the probability of OncoCyte Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoCyte Corp's price. Additionally, you may evaluate how the addition of OncoCyte Corp to your portfolios can decrease your overall portfolio volatility.